Balance Sheet
Cash Flow Statement
AcquisitionsAmortizationAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashChange in InventoryChange in ReceivablesChange in Working CapitalDeferred TaxesExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet Equity Issued and RepurchasedNet Income
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sanofi (SNY) Cash from Discontinued Operations (2024 - 2025)

Historic Cash from Discontinued Operations for Sanofi (SNY) over the last 2 years, with Q4 2025 value amounting to -$12.0 billion.

  • Sanofi's Cash from Discontinued Operations fell 32816.66% to -$12.0 billion in Q4 2025 from the same period last year, while for Dec 2025 it was -$6.2 million, marking a year-over-year change of. This contributed to the annual value of $213.6 million for FY2025, which is 5836.7% down from last year.
  • Sanofi's Cash from Discontinued Operations amounted to -$12.0 billion in Q4 2025, which was down 32816.66% from $8.3 billion recorded in Q3 2025.
  • Sanofi's 5-year Cash from Discontinued Operations high stood at $8.3 billion for Q3 2025, and its period low was -$12.0 billion during Q4 2025.